Income Statement Presentation 2023

FDA emergency use authorization for the mpox assay Running on cobas® 6800/8800 high throughput platforms Roche Throughput cobas® 6800 cobasⓇ 8800 EUA: Emergency Use Authorization Mpox assay NEW · · May 2022: Launch of LightMixⓇ modular virus kits for the detection of the mpox virus (on LightCycler instruments) November 2022: Received FDA EUA for the mpox assay run on cobas 6800/8800 within two months of regulatory pathway opening in September Roche fast response to the public health emergency contributed to fortifying its position and reputation in addressing outbreaks 43

View entire presentation